News | June 25, 2012

First ACE Accreditations Highlight Common Problem Areas in Cath Labs  

Incomplete records complicate evaluations of patient risk, PCI appropriateness

June 25, 2012 — The first 10 cardiac catheterization laboratories to undergo review by Accreditation for Cardiovascular Excellence (ACE) all welcomed the evaluation by outside experts. Still, review teams found insufficiencies in record-keeping and other quality metrics at well-run medical centers, according to two studies presented at the recent Society for Cardiovascular Angiography and Interventions (SCAI) 2012 Scientific Sessions.

Among the shortcomings found by the ACE review teams were medical records missing key clinical information, cardiac catheterization reports lacking data needed to determine patient risk and inconsistent use of random case reviews as a tool for ensuring quality and appropriateness. A significant amount of variation in documentation among sites was also seen during these reviews.

ACE accredits facilities that perform invasive cardiovascular procedures such as cardiac catheterization and percutaneous coronary intervention (PCI). The nonprofit organization, which was launched in May 2009 with support from SCAI and the American College of Cardiology Foundation, issued its first accreditation in May 2011.

As reported in the first study presented at SCAI, investigators gathered data on quality processes from the first 10 medical centers to undergo ACE review. They examined a total of 441 medical records from patients who underwent cardiac catheterization, PCI or both.

In the study, more than 93 percent of charts earned good marks for the completeness of most clinical data. However, certain areas needed improvement. Radiation exposure was documented in only 87 percent, and a combination of X-ray exposure time and absorbed radiation dose in 77.5 percent.

In addition, information on the severity of chest pain (angina class) was present in 28 percent of records, the extent of the risk associated with the patient’s coronary artery disease based on stress testing was stated in 8 percent and the patient’s functional status (New York Heart Association class) was stated in 21.8 percent of records. Other clinical information needed by the National Cardiovascular Data Registry (NCDR) to assess the risk of patients treated with PCI was missing from many records, making it difficult for reviewers to validate the accuracy of the data submitted to the database.

For the second study presented at SCAI 2012, physician reviewers from ACE examined 478 randomly selected angiograms and the accompanying cath reports from the same 10 facilities. They found that the results of PCI were adequate in 89 percent of cases. However, cath reports often contained insufficient or unclear information on patient risk and the appropriateness of PCI. For example, evidence that the patient’s heart muscle was not getting enough blood and oxygen (ischemia) was documented in only 46 percent of patients. About 8 percent of patients had intravascular ultrasound or another test to determine whether PCI was needed, but half of these studies were inadequate or indeterminate, and documentation was poor.

Overall, only 66 percent of non-urgent PCIs could be deemed appropriate based on the angiogram and information available in the cath report. In 26 percent of cases the appropriateness of PCI was considered uncertain primarily because of the limited documentation, while 8 percent of procedures were deemed inappropriate.

For more information:

Related Content

Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) datab
Videos | Cath Lab | September 14, 2018
A discussion with Nicolas Bevins, Ph.D., vice chair, physics and research, and Jessica Harrington, RCIS.
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and tre
Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Recent Acquisitions Eroding Prices in Billion Dollar European Interventional Cardiology cath lab Market.
Feature | Cath Lab | May 07, 2018 | Simon Trinh and Jeffrey Wong
The European interventional cardiology market is currently valued at nearly $1.4 billion.
Overlay Init